MDXH Competitors & Alternatives
Compare MDxHealth SA ADR with similar stocks in the same industry
Diagnostics & Research
MDXH
Main Stock$0.75
Tradestie Score
37
Market Cap
$231.40M
Revenue Growth
0.0%
Analyst Upside
+140.5%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$17.38
|
$1.13B | - | 43 | Compare |
|
CDNA
CareDx, Inc.
|
$50.88
|
$798.40M | 24.0 | 35 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$19.73
|
$719.31M | - | 54 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$32.91
|
$667.77M | - | 39 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$17.20
|
$612.76M | - | 37 | Compare |
|
NYXH
Nyxoah SA Ordinary Shares
|
$1.62
|
$185.47M | - | 43 | Compare |
|
SERA
Sera Prognostics, Inc. Class A Common Stock
|
$2.02
|
$112.28M | - | 46 | Compare |
|
LUCD
Lucid Diagnostics Inc. Common Stock
|
$0.94
|
$103.93M | - | 45 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$26.18
|
$61.36M | - | 47 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$1.21
|
$3.50M | - | 41 | Compare |
More MDXH Analysis
Data updated: Sep 06, 2026 | Industry: Diagnostics & Research (SIC 8071)
39 stocks in this industry